Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-1918 in homozygous familial hypercholesterolemia
NCT06723652Phase 3Completed
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd.
- Start
- Feb 2025
- Primary completion
- Aug 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of SHR-1918 in homozygous familial hypercholesterolemia (HoFH), sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd.. Started Feb 2025; status: completed.
02
Drugs
SHR-1918
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT06723652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06723652.